Smith RA - Search Results

1

Chemical derivatization of therapeutic proteins.

Smith RA, Dewdney JM, Fears R, Poste G. Smith RA, et al. Trends Biotechnol. 1993 Sep;11(9):397-403. doi: 10.1016/0167-7799(93)90100-N. Trends Biotechnol. 1993. PMID: 7764087 Review.

2

The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

Cassels R, Fears R, Smith RA. Cassels R, et al. Among authors: smith ra. Biochem J. 1987 Oct 15;247(2):395-400. doi: 10.1042/bj2470395. Biochem J. 1987. PMID: 3122725 Free PMC article.

3

Chemical methods of protein synthesis and modification.

Humphries J, Offord RE, Smith RA. Humphries J, et al. Among authors: smith ra. Curr Opin Biotechnol. 1991 Aug;2(4):539-43. doi: 10.1016/0958-1669(91)90078-j. Curr Opin Biotechnol. 1991. PMID: 1367673 Review.

4

Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.

Fears R, Hibbs MJ, Smith RA. Fears R, et al. Among authors: smith ra. Biochem J. 1985 Jul 15;229(2):555-8. doi: 10.1042/bj2290555. Biochem J. 1985. PMID: 4041182 Free PMC article.

5

Induction of a sustained fibrinolytic response by BRL 26921 in vitro.

Fears R, Green J, Smith RA, Walker P. Fears R, et al. Among authors: smith ra. Thromb Res. 1985 May 1;38(3):251-60. doi: 10.1016/0049-3848(85)90153-7. Thromb Res. 1985. PMID: 3895561

6

Production and characterization of recombinant proteins for NMR structural studies.

Mossakowska DE, Smith RA. Mossakowska DE, et al. Among authors: smith ra. Methods Mol Biol. 1997;60:325-35. doi: 10.1385/0-89603-309-0:325. Methods Mol Biol. 1997. PMID: 9276253 Review. No abstract available.

7

The use of active centre acylation to control the pharmacokinetic profile of a recombinant chimaeric plasminogen activator.

Wilson S, Cronk DW, Dodd I, Esmail AF, Kalindjian SB, McMurdo L, Browne MJ, Smith RA, Robinson JH. Wilson S, et al. Among authors: smith ra. Thromb Haemost. 1993 Dec 20;70(6):984-8. Thromb Haemost. 1993. PMID: 8165622

8

Overexpression in Escherichia coli, folding, purification, and characterization of the first three short consensus repeat modules of human complement receptor type 1.

Dodd I, Mossakowska DE, Camilleri P, Haran M, Hensley P, Lawlor EJ, McBay DL, Pindar W, Smith RA. Dodd I, et al. Among authors: smith ra. Protein Expr Purif. 1995 Dec;6(6):727-36. doi: 10.1006/prep.1995.0003. Protein Expr Purif. 1995. PMID: 8746624

9

Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730).

Smith EF 3rd, Griswold DE, Egan JW, Hillegass LM, Smith RA, Hibbs MJ, Gagnon RC. Smith EF 3rd, et al. Among authors: smith ra. Eur J Pharmacol. 1993 Jun 4;236(3):477-81. doi: 10.1016/0014-2999(93)90487-3. Eur J Pharmacol. 1993. PMID: 8395386

10

The use of bovine fibrin-streptokinase films for the determination of recombinant human plasminogen.

Dodd I, Mitchell DL, Chapman CG, Smith RA. Dodd I, et al. Among authors: smith ra. Biologicals. 1992 Sep;20(3):197-202. doi: 10.1016/s1045-1056(05)80038-7. Biologicals. 1992. PMID: 1457105

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,953 results

Search Page

Filters